baber/WOPTO huggingface dataset:
Patent AT-E261329-T1 (AT)
Inventor: ST GOAR FREDERICK G
IPC: A61B17/00
Filed: 1995-11-21
Granted: 2004-03-15
Abstract: A catheter system is provided for accessing the coronary ostia transluminally from a peripheral arterial access site, such as the femoral artery, and for inducing cardioplegic arrest by direct infusion of cardioplegic solution into the coronary arteries. In a first embodiment, the catheter system is in the form of a single perfusion catheter with multiple distal branches for engaging the coronary ostia. In a second embodiment, multiple perfusion catheters are delivered to the coronary ostia through a single arterial cannula. In a third embodiment, multiple perfusion catheters are delivered to the coronary ostia through a single guiding catheter. In a fourth embodiment, multiple catheters are delivered to the coronary ostia through a single guiding catheter which has distal exit ports that are arranged to direct the perfusion catheters into the coronary ostia. In each embodiment, the catheters are equipped with an occlusion means at the distal end of the catheter for closing the coronary ostia and isolating the coronary arteries from the systemic blood flow. The occlusion means can take the form of an inflatable occlusion balloon cuff, a tapered occlusion device or an O-ring encircling the distal end of the catheter. An optional ventricular venting catheter can be included in the system for venting blood and fluids from the left ventricle of the heart. The catheter system is combined with a femoral-to-femoral cardiopulmonary bypass system to provide a system for cardioplegic arrest and total cardiopulmonary support during minimally invasive cardiac surgical procedures.
Patent AT-E240390-T1 (AT)
Inventor: KLEIN ANTOINETTE
IPC: A61K48/00
Filed: 1995-12-18
Granted: 2003-05-15
Abstract: A method is disclosed for gene transfer into a culture of primitive stem cells which comprises a prestimulation step of adding a blocking agent to block at least one inhibitor of a cell cycle of said primitive stem cells. The prestimulation is time-limited for a period of less than approximately 36 hours so that said culture of primitive stem cells retains hematopoietic potential.
Patent AT-E208885-T1 (AT)
Inventor: KLAS ERNST
IPC: B41F23/04
Filed: 1996-11-06
Granted: 2001-11-15
Abstract: A suspension dryer for freshly moisturized webs of swellable paper has a row of lower nozzle beams which extend transversely to a throughgoing direction so as to be spaced from one another along a dryer length with a distance from one another and provided at an upper side with blowing openings, a row of upper nozzle beams extending transversely to the throughgoing direction at a distance from one another along the dryer length so as to be offset relative to the lower nozzle beams and provided on a lower side with blowing openings, a width of the nozzle beams arranged in an initial portion of the dryer length is greater than a width of the nozzle beams arranged in the remaining portion of the dryer length, and a distance between two adjacent ones of the nozzle beams arranged in the initial portion is greater than a distance between two adjacent ones of the nozzle beams arranged in the remaining portion.\!
Patent AT-E196644-T1 (AT)
Inventor: BOCHMANN GERD DIPL-CHEM
IPC: C09B67/02
Filed: 1996-11-18
Granted: 2000-10-15
Abstract: The prepn. of instant paint powder comprises: (1) making a pigment-extender particle (I) by pressing a pigment grain onto an extender grain in the presence of a surfactant (wetting agent); (2) absorbing an additive concentrate mixt. in liquid and/or pasty form on (I); (3) contacting and mixing (I) with a dispersion powder; and (4) homogenising.
Patent AT-E263589-T1 (AT)
Inventor: MONTEVECCHI FRANCO
IPC: F04B53/10
Filed: 1996-02-05
Granted: 2004-04-15
Abstract: A device for the pulsed pumping of liquids, particularly blood, has a body in which are formed a pumping chamber in which a pulsed flow is imparted to the liquid, an inlet duct upstream of the pumping chamber and communicating therewith, and a delivery duct downstream of the pumping chamber and communicating therewith. The shape of the pumping chamber is annular. Two valve members constituted by lip valves are provided for regulating the one-way flow of fluid in the body from the inlet duct to the pumping chamber and from the latter to the delivery duct. A diaphragm disposed within the pumping chamber is movable between a first position and a second position in a reciprocating manner such that pulsed flow is imparted to the liquid. The diaphragm has an annular configuration and a substantially "C" shaped cross section. The pumping device may be incorporated into a cardiopulmonary bypass device which includes a venous reservoir, a heat exchanger and an oxygenator. <IMAGE>
Patent AT-E185731-T1 (AT)
Inventor: TOULOUSE BRUNO
IPC: B25C1/08
Filed: 1996-01-10
Granted: 1999-11-15
Abstract: The nail gun comprises a piston (6) propelled by compressed gas inside a cylinder (3). It also has a nail guide (5), a sleeve (4) for a combustion chamber (10), and a head (2) equipped with an igniter. A gas reservoir feeds an injector (17), whilst a feeler opens and closes the chamber. The cylinder is able to move inside the housing of the gun. The nail guide ensures the operation of the feeler and moves together with the cylinder, which also contains piston retaining elements (32). During operation a charge of gas is let into the combustion chamber, where it is mixed with air by a fan and then ignited, causing the piston to travel forwards and driven in the nail (15).
Patent AT-E177998-T1 (AT)
Inventor: HUART GILBERT
IPC: B60B33/00
Filed: 1996-01-23
Granted: 1999-04-15
Abstract: The castor wheel comprises a plastics wheel body (25) which surrounds an internal bearing (21) on an axle (20) fixed to a clevis which rotates on a support bearing. The internal bearing has external (22) and internal (23) collars with ball bearings (24) interposed between them. The wheel body has a hub (33) which extends axially from either side of the external collar and a rim (34) which supports a tyre (26). A wheel web (35) connects the rim to the hub. The wheel is mounted on the axle by two bell shaped annular retaining wires (40) located either side the hub. Each wire has a sleeve (42) acting as a brace whose internal end portion (43) is interposed between the internal collar and the axle. The other part of the sleeve has a stop surface (45) supported on the adjacent front face of the internal collar.
Patent AT-E164830-T1 (AT)
Inventor: GALEY JEAN-BAPTISTE
IPC: A61K8/30
Filed: 1996-07-25
Granted: 1998-04-15
Abstract: N,N'-di(aralkyl)- or N-(aralkyl)-N'-(carboxyalkyl)- N,N'- di-(carboxyalkyl) alkylene di- and triamine derivs. of formula (I) and their salts and metal complexes are new. In (I), n = 0-2; m, p = 1-3; R and R1-R4 = H or 1-4C alkyl; or R1+R2, R2+R3 = a 5- or 6-membered ring; X = COOR4 or gp. of formula (i) or (ii; p = 1 ); Z1-Z3 = H, 1-4C alkyl, OR5 or NR5R'5; R5, R'5 = H or 1-4C alkyl; with proviso that when n = 0, m = 1 and X = -COOR4 or gp. (ii) then at least one of R, R1 and R2 is other than H.
Patent AT-E183440-T1 (AT)
Inventor: PEDERSEN FLEMMING STEEN
IPC: B41C1/10
Filed: 1996-05-01
Granted: 1999-09-15
Abstract: PCT No. PCT/DK96/00200 Sec. 371 Date Oct. 31, 1997 Sec. 102(e) Date Oct. 31, 1997 PCT Filed May 1, 1996 PCT Pub. No. WO96/34747 PCT Pub. Date Nov. 7, 1996A laser exposure apparatus for exposing exposure material (6), such as light-sensitive offset printing plates. The apparatus comprises a relatively heavy base member and an optical scanning unit (2) employing a movable mirror for deflecting a laser beam. The base member (1) comprises a substantially semi-cylindrical exposure surface (5), on which the exposure material (6) can be placed. A bridge (7) is arranged above the base member (1), said bridge being displaceable along the base member in the longitudinal direction thereof by means of an advancing device (8), the mirror being placed on said bridge. The advancing device (8) is arranged along one side of the base member, and the bridge is mounted in a completely or almost completely balanced manner relative to the advancing device (8) by means of a counterweight (9) provided on a projecting portion (7') of the bridge (7), the center of gravity (G) of said counterweight being placed on the other side of the advancing device (8). The bridge (7) can optionally rest on longitudinal supporting surfaces (10', 10'', 10''') on the base member (1). As a result, an increased accuracy is obtained in connection with the exposure of the exposure material.
Patent AT-E221769-T1 (AT)
Inventor: DONG LIANG C
IPC: A61K31/57
Filed: 1996-05-29
Granted: 2002-08-15
Abstract: The present invention is directed to a fluid-imbibing drug delivery device which is useful for the initial delayed delivery of an active agent formulation to a fluid environment of use, the initial delay period to startup or activation of the device being of a predetermined length of time. The delivery of the agent formulation from the dispensing device is continued until essentially all of the active agent formulation is delivered as a result of the expansion of an expansion agent in the active agent delivery chamber.
Patent AT-E377418-T1 (AT)
Inventor: GRAINGER DAVID J
IPC: G01N33/566
Filed: 1996-06-07
Granted: 2007-11-15
Abstract: A method for treating or preventing cardiovascular pathologies by administering a compound of the formula (I): wherein Z is C-O or a covalent bond; Y is H or O(C<SUB>1</SUB>-C<SUB>4</SUB>)alkyl, R<SUP>1 </SUP>and R<SUP>2 </SUP>are individually (C<SUB>1</SUB>-C<SUB>4</SUB>)alkyl or together with N are a saturated heterocyclic group, R<SUP>3 </SUP>is ethyl or chloroethyl, R<SUP>4 </SUP>is H, R<SUP>5 </SUP>is I, O(C<SUB>1</SUB>-C<SUB>4</SUB>)alkyl or H and R<SUP>6 </SUP>is I, O(C<SUB>1</SUB>-C<SUB>4</SUB>)alkyl or H with the proviso that when R<SUP>4</SUP>, R<SUP>5</SUP>, and R<SUP>6 </SUP>are H, R<SUP>3 </SUP>is not ethyl; or a pharmaceutically acceptable salt thereof, effective to elevate the level of TGF-beta to treat and/or prevent conditions such as atherosclerosis, thrombosis, myocardial infarction, and stroke is provided. Useful compounds include idoxifene, toremifene or salts thereof. Further provided is a method for identifying an agent that elevates the level of TGF-beta. Another embodiment of the invention is an assay or kit to determine TGF-beta in vitro. Also provided is a therapeutic method comprising inhibiting smooth muscle cell proliferation associated with procedural vascular trauma employing the administration of tamoxifin or structural analogs thereof, including compounds of formula (I).
Patent AT-E250425-T1 (AT)
Inventor: DONG ZHENG XIN
IPC: A61K38/00
Filed: 1996-07-03
Granted: 2003-10-15
Abstract: Peptide variants of fragment (1-34) of parathyroid hormone, in which at least one of the amino acid residues at positions 7, 11, 23, 24, 27, 28 and 31 is cyclohexylalanine, or at least one of the amino acid residues at positions 3, 16, 17, 18, 19 and 34 is  alpha -aminoisobutyric acid; or, alternatively, at least the amino acid residue at position 1 is  alpha , beta -diaminopropionic acid, the amino acid residue at position 27 is homoarginine, or the amino acid residue at position 31 is norleucine.
Patent AT-E330018-T1 (AT)
Inventor: COLLINS MARY KATHARINE LEVINGE
IPC: C12N15/67
Filed: 1996-08-23
Granted: 2006-07-15
Abstract: PCT No. PCT/GB96/02061 Sec. 371 Date Jun. 22, 1998 Sec. 102(e) Date Jun. 22, 1998 PCT Filed Aug. 23, 1996 PCT Pub. No. WO97/08330 PCT Pub. Date Mar. 6, 1997The invention relates to new expression systems and in particular to an expression system in which a gene of interest is expressed at an optimal level. The invention provides a recombinant expression vector comprising a gene of interest and a selectable marker gene, wherein the selectable marker gene is arranged downstream of the gene of interest and a stop codon associated with the gene of interest is spaced from a start codon of said selectable marker gene at a distance which is sufficient to ensure that translation reinitiation is required before said selectable marker protein is expressed from the corresponding mRNA. Examples of such expression systems are vector viral packaging cell lines and a number of preferred cell lines have been identified.
Patent AT-E200422-T1 (AT)
Inventor: AMMON HERMANN P T
IPC: A61K36/00
Filed: 1996-08-22
Granted: 2001-04-15
Abstract: The invention concerns the use of pure boswellic acid, a physiologically acceptable salt, a derivative, a salt of the derivative or a plant preparation containing boswellic acid for preventing and/or combatting diseases which are caused by increased leucocytic elastase or plasmin activity or can be treated by the inhibition of, normal leucocytic elastase or plasmin activity, in human or veterinary medicine. The invention further concerns the use of pure boswellic acid or a physiologically acceptable salt, a derivative, a salt of the derivative or a plant preparation containing boswellic acid for preparing a medicament for treating diseases which are caused by increased leucocytic elastase or plasmin activity or can be treated by the inhibition of normal leucocytic elastase or plasmin activity, in human or veterinary medicine.
Patent AT-E220899-T1 (AT)
Inventor: LAURENT PHILIPPE
IPC: A61K9/12
Filed: 1996-10-17
Granted: 2002-08-15
Abstract: A composition is intended to form on the skin, by spraying from an erasol can, a film for the transdermal administration of an active agent, and the composition contains 0.01-10% by weight of lipophilic vitamins, hormones, nicotine, corticoids, retinoids, antimycosic agents, anistetics, anolgesics, or anti cancer agents for the skin, 0.5 to 25% by weight of an adhesive polysiloxane composition, 5 to 25% by weight of an absorption promoter, 25 to 95% by weight of a volatile solvent containing at least a volatile silicone, and 0.5 to 50% by weight of pressurized propellant gas, and the composition is substantially free from water.
Patent AT-E219617-T1 (AT)
Inventor: BIJL PIETER
IPC: H04N5/33
Filed: 1997-03-21
Granted: 2002-07-15
Abstract: Test system for viewing systems, such as CCD cameras, infrared viewers, or binoculars or telescopes, which test system is provided with a test object having various component test objects to be shown to the viewing system, which test object is to be placed at a distance from the viewing system and which is to be rendered displayable with the viewing system for an inspection unit (for example, a test operative), with which inspection unit the quality of the operation of the viewing system can be determined on the basis of said display, the test object comprising component test objects differing in appearance from one another and the test system being suitable for presenting said component test objects simultaneously or one after another to the inspection unit to determine a property of the displayed component test objects. <IMAGE>
Patent AT-E266916-T1 (AT)
Inventor: BELVEZE FABRICE
IPC: H04L1/04
Filed: 1997-07-21
Granted: 2004-05-15
Abstract: The method involves a receiver which performs N demodulations, forming a number of binary symbol estimates. Each estimate is a real number, with the sign used to represent the most probable value. The receiver estimates the value of a bit in the range using an algorithm which investigates the difference between estimated and verified bits to provide the bit value which has the maximum likelihood of being correct.
Patent AT-E273359-T1 (AT)
Inventor: TROSA ALESSANDRO
IPC: C08L61/24
Filed: 1997-12-15
Granted: 2004-08-15
Abstract: A thermosetting adhesive composition based on condensed tannins comprises a hardening agent selected from the group which consists of:   A) products of the reaction of a nitroparaffin with formaldehyde in an alkaline medium, of the general formula: <CHEM> in which R1 and R2 are selected, independently of one another, from C1-C4 alkyl and C1-C4 hydroxyalkyl groups; B) water-miscible urea-formaldehyde and melamine-formaldehyde condensation products with degrees of polymerization no greater than 4; C) products of the reaction of formaldehyde, in a basic medium, with urea-carbohydrate adducts, the adducts being products of the reaction of urea with a carbohydrate in an anhydrous medium, in the fused state.
Patent AT-E210864-T1 (AT)
Inventor: WILM ROBERT
IPC: B42D15/10
Filed: 1997-09-22
Granted: 2001-12-15
Abstract: The invention concerns a process and a connecting arrangement for producing a chip card, wherein a semiconductor chip on a module is fitted in an opening in a card carrier with the attainment of an electrical and mechanical connection. In accordance with the invention, in place of connections which were hitherto necessary involving a force-locking relationship and/or involving the materials being bonded together, recourse is made to inductive and/or capacitive coupling between the module and the IC-card. For that purpose the module and the card correspondingly have coils and/or capacitive coupling surfaces for signal transmission purposes.
Patent AT-E213266-T1 (AT)
Inventor: NITSCH CHRISTIAN
IPC: C11D3/20
Filed: 1997-03-22
Granted: 2002-02-15
Abstract: The pH of an aqueous treatment solution is to be automatically adjusted from the acid to the alkaline. This is achieved in that the desired acid pH is set in an aqueous bath with the simultaneous or subsequent addition of an ammonia-generating and/or organic carboxylic acid-consuming enzyme and its substrate, whereupon the enzymatic reaction is allowed to continue until the desired final pH is attained.
Patent AT-E206411-T1 (AT)
Inventor: VAN WIJCK JULIUS GERARDUS THEO
IPC: C07D251/60
Filed: 1997-07-21
Granted: 2001-10-15
Abstract: The invention relates to a high-pressure process for producing melamine from urea in which highly pure melamine is obtained by transferring melamine melt leaving a melamine reactor to a cooling vessel where the melamine melt is cooled to a temperature of between 1° C. and 30° C. above the melting point of melamine after which the liquid melamine can be transferred to a second cooling vessel in which vessel the melamine melt is further cooled using cold ammonia by which solid melamine is obtained.
Patent AT-E252891-T1 (AT)
Inventor: BISCHOFF RAINER
IPC: A61K9/127
Filed: 1997-08-25
Granted: 2003-11-15
Abstract: The invention is related to a method for preparing an homogenous suspension of stable lipid-nucleic acid complexes or particles, comprising: a) combining one or more cationic lipids, one or more colipids, and one or more stabilizing additives to form a lipid suspension, b) combining the lipid suspension with a nucleic acid to form a complex or a particle, and optionally c) subjecting the complex or particle to a sizing procedure. It also concerns an homogenous suspension produced notably by the above method.
Patent AT-E353536-T1 (AT)
Inventor: KYDD PAUL H
IPC: B22F1/00
Filed: 1997-09-12
Granted: 2007-02-15
Abstract: A composition for matter having a metal powder or powders for specified characteristics in a Reactive Organic Medium (ROM). These compositions can be applied by any convenient printing process to produce patterns of electrical conductors on temperature-sensitive electronic substrates. The patterns can be thermally cured in seconds to form pure metal conductors at a temperature low enough to avoid damaging the substrate.
Patent AT-E270962-T1 (AT)
Inventor: BABROWICZ ROBERT
IPC: B29C35/08
Filed: 1997-03-25
Granted: 2004-07-15
Abstract: The present invention generally relates to polymeric compositions capable of providing enhanced crosslinking efficiency, to single and multilayer films having the subject composition contained within at least one layer of said film, to a method of treating said film to provide enhanced crosslink within said at least one layer of the film and to the resultant cross-linked film product as well as articles made from said cross-linked film product.
Patent AT-E220605-T1 (AT)
Inventor: JONES RICHARD ALBERT
IPC: B29C43/02
Filed: 1997-10-06
Granted: 2002-08-15
Abstract: A polyolefin plaque is made by hot compaction of an assembly of fibres of the oriented polymer. It has been found to be beneficial to subject the fibres to a prior crosslinking process. Hot compaction is then less temperature-sensitive and produces plaques with excellent hot strength properties. Preferably the fibres have been subjected to prior stages of irradiation and annealing, both in a non-oxidising environment, for example acetylene.
Patent AT-E299639-T1 (AT)
Inventor: KRISHNAMURTHI RAJEEV
IPC: H04W4/16
Filed: 1997-09-26
Granted: 2005-07-15
Abstract: The invention is a method and apparatus for providing an Alert With Information Message signal between a mobile switching center (36) and a base station (34) in a cellular communication system. The invention recognizes that current provisions of the IS-634 standard lack support for certain required functionality on the interface between a mobile switching center (36) and a base station (34), or the A-Interface. An Alert With Information Message signal is introduced on the A-Interface to support the required functionality. Introduction of the Alert With Information Message provides support for reliable call processing on the A-Interface for the call waiting procedure, the hard handoff procedure, and the resolution of a glare condition. A message generator (38) in the mobile switching center (36) generates the Alert With Information Message, which is transmitted to message receiver (40) in the base station (34) when needed.              00000
Patent AT-E223565-T1 (AT)
Inventor: CURRID STEVE
IPC: E03C1/122
Filed: 1997-12-04
Granted: 2002-09-15
Abstract: A non-return device (10) comprises a flat silicone rubber tubing (50) defining a pair of walls (70, 90) which separate to admit fluid in a forward direction but remain together to block fluid flow in a reverse direction. A tubular body (30) surrounds the tubing (50) and comprises an off-set outlet (34) to provide an uninterrupted fluid flow surface for use in a non-vertical orientation. The tubing (50) is mounted on a cartridge (130) which moves axially within the tubular body and compresses the tubing against the tubular body to effect a seal when the device is mounted on an outlet. The tubing (50) provides good operational characteristics and sensitivity as a consequence of having a wall thickness which is 0.3% to 3% of its width.
Patent AT-E277124-T1 (AT)
Inventor: BASTIOLI CATIA
IPC: C08K5/10
Filed: 1997-11-05
Granted: 2004-10-15
Abstract: Polymeric compositions comprising thermoplastic starch and a thermoplastic polymer incompatible with starch, in which the starch constitutes the dispersed phase and the thermoplastic polymer constitutes the continuous phase, selected:A) from compositions comprising an agent with an interfacial effect selected from esters of polyols with mono- or polycarboxylic acids with dissociation constants within certain limits, the esters having specific values of the hydrophillic/lipophilic balance index HLB or being amongst the non-ionic surfactants which are soluble in water but cannot significantly be extracted by water from the compositions which contain them,B) from compositions wherein the thermoplastic polymer is an aliphatic or aliphatic-aromatic copolyester wherein the ratio R between the average viscometric molecular weight and the melt index is greater than 25,000 andC) from compositions wherein the thermoplastic polymer is selected from aliphatic-aromatic copolyesters, polyester-amides, polyester-ethers, polyester-ether-amides, polyester-urethanes and polyester-ureas and wherein the compositions are obtained by extrusion of the component maintaining a water content during the mixing stage from 1 to 5% by weight.